Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 601

16 ASX stocks to buy and hold forever, updated

One of my most popular articles from last year was one entitled 16 ASX stocks to buy and hold forever. I think it sparked interest for a few reasons. First, owning stocks that can compound returns at a high rate is an attractive proposition. Second, a number of investors have very long timeframes and there isn’t much in the financial press that caters to these investors.

One year on, I thought it’d be worth revisiting the article to answer the many questions I’ve got from readers since that time, including what stocks on the list may be worth buying now and whether I’d make any changes to the list.

The 16 stocks I chose

Let’s quickly recap the premise of the original article. I got the idea from Warren Buffett, who had famously named several stocks that he’d like his company, Berkshire Hathway, to own forever, including Coca-Cola, American Express, Occidental Petroleum, and the Japanese trading companies.

I thought I could take that and apply it to the local share market. It wasn’t an easy task because I had to be confident that the companies could last indefinitely, and that they had enough growth opportunities to allow them to achieve shareholder returns that beat the ASX 300 index (otherwise, why own them?).

To help with the task, I created seven criteria to identify the ASX stocks that could be held indefinitely:

  1. Part of the ASX 300
  2. Long runway of growth opportunities
  3. Economic moats
  4. Good returns on capital
  5. Sound balance sheets
  6. Don’t rely on exceptional managers to succeed
  7. Unlikely to be disrupted

From these criteria, I chose 16 stocks that you could hold forever:


Source: Morningstar, Firstlinks

To be clear, the list wasn’t a case of buying now and holding forever. It was a wish list of potential stocks to own in future and own indefinitely.

Are there really forever stocks?

One query I got was what I meant by ‘forever’. In a follow-up interview I did with Morningstar’s Mark LaMonica, I clarified that my timeframe for forever was 50+ years.

I also got scepticism about whether any stocks really could be held indefinitely. After all, studies show the average lifespan of an S&P 500 company is around 15 years. The scepticism has merit, though it doesn’t preclude finding special companies that can buck that trend.

One year on, would I change the list?

Yes, I would. In hindsight, there are two weak links in the list. The first is Argo Investments. Put simply, its portfolio returns are continuing to disappoint. I thought it might be a temporary blip, but it has been underperforming for a long period, and there doesn’t seem to be any turnaround to that. My error was that I got caught up in its long history, stable management, and decent returns over almost 80 years. However, as a fund manager, it’s performance that matters, and on that front, its ‘glory days’ appear to be behind it. Consequently, I would eliminate this one from the list.

Some investors have also questioned the merits of Australian Foundation Investment given its recent underperformance. I’ve got more faith that management will turn it around and deliver outperformance in future.

The other stock I have on my watchlist is Aurizon. When I featured it in the list, I said that I love the railroad business. Railroads have cost advantages for bulk transportation that won’t go away. And there are long-term contracts with imbedded price increases. And though Aurizon gets 80% of its earnings from coal haulage, I’m more optimistic than most on coal volumes over the next decade, plus I’m buoyed also by the company’s gradual transition to non-coal transportation.

One thing I may have underestimated is the competition in the industry. That impacts both rate and volumes.

I’m keeping a close eye on this, but for now, I think Aurizon should remain on the list.

The other company that may raise eyebrows is SkyCity. It’s had a horror run, with regulatory crackdowns, a New Zealand economy that’s been in recession, and a broader casino industry that’s been on the nose.

Yet, I’m still a believer in the long-term future of the company given its long-dated and exclusive licences in Auckland and Adelaide. It remains a keeper.

In saying that, the biggest lesson that I’ve learned over the past 12 months is that sometimes the biggest competitive advantage for a company can also be its largest risk. That’s especially the case for companies that have government licences and contracts.

For SkyCity, its economic moat comes from its exclusive casino licences. But we’ve seen increased regulatory scrutiny in New Zealand of late. And in Australia, Crown and Star have encountered the wrath of Governments after decades of friendly regulatory oversight.

We’ve also seen that with another stock on the list: Transurban. Pressure continues for it to renegotiate toll road contracts after a review recommending as such. This is another one to keep a close watch on, though I remain confident that any change to contracts will be adequately compensated and that there are still ample growth opportunities ahead for the company.

What other stocks could be considered for the list?

There are four stocks that were unlucky not to make the original list:

  1. Brambles (ASX: BXB). Wooden pallets are an old technology but it doesn’t look like being replaced any time soon. Brambles is a leader in the industry, operating in 60 countries. Demand for its products should continue to grow given most of its business comes from fast-moving consumer goods.
  2. ARB (ASX: ARB). This company has grown from a local bull bar manufacturer to become a global automotive accessory leader. It’s accelerating its push into the US, recently increasing its stake in Off Road Warehouse, the largest 4x4 accessory retailer in America. Lots of growth opportunities, great returns on capital, and a proven management team make ARB a potential keeper for the long-term.
  3. Goodman Group (ASX: GMG). Greg Goodman is a smart guy who knows how to scale a business and make a buck (or billions of bucks). His pivot into data centres seems well timed and should pay off given the increasing commoditisation of AI should drive greater demand for AI and data centres. Meanwhile, the industrial property business remains well-placed given the rise and rise of e-commerce.
  4. Aristocrat Leisure (ASX: ALL). Aristocrat’s gaming machine business operates in a mature industry but with licencing requirements that limit new players coming into the market. In recent years, it’s expanded into the fast-growing mobile gaming market. This move should drive growth for the company, which has become one of Australia’s biggest overseas success stories.

I mentioned above that I would eliminate Argo from the list of stocks to own forever. In its place, I would choose either Brambles or ARB.

What stocks on the list are worth buying now?

There are six ‘forever’ stocks that I believe are potentially worth buying now:

  • ASX Ltd
  • Aurizon
  • SkyCity
  • Medibank Private
  • The Lottery Corporation
  • Washington H Soul Pattinson

The top three stocks here have all encountered what I consider temporary setbacks. I wrote of Aurizon and SkyCity above. On ASX, it has proven my point in the original article that you want to own companies that don’t rely on exceptional managers to succeed. Because leaders of ASX have failed at a lot of things, and yet the quality of the company is undiminished. Of all the companies, ASX Ltd is my strongest buy idea.

The remaining three companies that I think are potential buys are high quality businesses offering reasonable value. Medibank Private continues to show its strength in an industry that should continue to grow for decades to come. The Lottery Corporation is a great company. Yes, it has regulatory licences, though it seems highly unlikely that Governments will undermine the company’s monopolies in markets. Washington H Soul Pattinson is a proven, canny investor. One wonders if Perpetual or parts of it may be in play for Soul Patts at some stage.

Which of the stocks are overvalued now?

Of the 16 stocks on the list, which are the ones to avoid right now? I would name three:

  • REA
  • Cochlear
  • Wesfarmers

All three companies are high quality, and all are priced for perfection, and beyond.

I considered REA incredibly expensive at this time last year, and the stock is up 33% since! It’s now trading at 18x sales and 53x earnings. The move by Costar on REA rival, Domain, may be the catalyst for a reality check in the REA share price. CoStar is a proven operator with deep pockets and investors may soon fret about the potential implications for REA.

Cochlear’s share price has taken a hit over the past 12 months, yet at 46x earnings, it still seems very overpriced. I think the company can grow profits by high single digits over the next few decades, but there’s no way I’d pay a 46x multiple for that.

Wesfarmers is another that seems overpriced. Again, though, I thought the same thing last year, and it’s performed ok since.

 

James Gruber is an assistant editor at Firstlinks and Morningstar.com.au.

 

11 Comments
John Collins
March 07, 2025

why would you take a punt of individual stocks on ASX when you can buy Vanguard VAS etf for a very marginal cost.

Derek D
March 06, 2025

There was an excellent article by Greg Canavan (Fat Tail Investment Research) titled, 'Are you really a long-term investor'. The research suggests the average holding period for US Equities has reduced from 5 years to as low as 10 months on average. It notes that the trend over decades has been towards more trading and less buy-to-hold investing. A buy-to-hold or long-term strategy is seemingly now out of favour. I believe it was Buffett who was quoted to have declared, "The stock market is a device for transferring money from the impatient to the patient".

Anthony Gross
March 06, 2025

Hi James,
I suggest you have slightly mis-characterised Warren Buffet's words. For example, over the last 12 months, WB has sold part of his holdings in Apple and Bank of America. Both of which I thought he described as permanent holdings. As well as various questions in AGM he has expressed regret (my word) or similar thoughts at not reducing his stake in Coke when it was trading at P/E's of 30 to 40.

Apart from this, I think the thrust of your article is good.

As well the holding time from retail investors on the NYSE has fallen from 2 years to 7 months. This data may be out of date. But your thoughts on a longer investment time frame is a good warning against over-trading.

James Gruber
March 06, 2025

Hi Anthony,

Buffett never named Apple and Bank of America as stocks he'd like Berkshire to own forever. His comments on Coke were more recently on being a forever stock, though earlier, you are right, he did regret not selling it.

I've noted in previous articles that the silence on Apple being a forever stock was perhaps a clue to his subsequent actions (to sell down).

James

GB
March 06, 2025

Wow. You certainly love the betting companies. What alternatives do you suggest for those who have grave misgivings supporting such a parasitic industry?

James Gruber
March 06, 2025

Hi GB,

Four possible inclusions are mentioned in the article (three non-gaming). 

James

James Gruber
March 06, 2025

Hi CC,

They are possiblities. However, I think CSL is suffering somewhat from the tyranny of size, and I wrote about that here: https://www.firstlinks.com.au/welcome-firstlinks-edition-577

As for Resmed, I am more wary than consenus when it comes to the impact of GLPs on the business. The jury is still out.

James

CC
March 06, 2025

GLPs are very overrated, very expensive, cause lots of unpleasant side effects and many people with OSA are not obese anyway.
Anecdotally the drugs have been beneficial for RMD as its brought more awareness of OSA as an issue, and their EPS have continued growing regardless of the GLPs just as RMD has done consistently for the past 20 years. Arguably the most consistent long term EPS grower on the ASX .

James Gruber
March 06, 2025

Hi CC,

I think GLPs will get much cheaper and better, quickly, and that will test the market more. Let's see.

James

Ian Nettle
March 06, 2025

All good points CC. I know a number of people using these drugs and they all downplay the side effects (to the extent....what side effects?). All they talk about is the energy they have found. Overall, when I look at the size of my fellow Australian's it leaves me in despair.

Investing I have sold out of RMD for the first time ever and I am invested in NVO and LLY and a smaller holding in Amgen all in the US. I would rather see people eat less and exercise more but I observe that it must be just too hard?

CC
March 06, 2025

CSL and Resmed ?

 

Leave a Comment:

RELATED ARTICLES

16 ASX stocks to buy and hold forever

11 ASX dividend stocks for the next decade

Why August company reporting season was poor

banner

Most viewed in recent weeks

UniSuper’s boss flags a potential correction ahead

The CIO of Australia’s fourth largest super fund by assets, John Pearce, suggests the odds favour a flat year for markets, with the possibility of a correction of 10% or more. However, he’ll use any dip as a buying opportunity.

Retirement is a risky business for most people

While encouraging people to draw down on their accumulated wealth in retirement might be good public policy, several million retirees disagree because they are purposefully conserving that capital. It’s time for a different approach.

Is Gen X ready for retirement?

With the arrival of the new year, the first members of ‘Generation X’ turned 60, marking the start of the MTV generation’s collective journey towards retirement. Are Gen Xers and our retirement system ready for the transition?

Reform overdue for family home CGT exemption

The capital gains tax main residence exemption is no longer 'fit for purpose', due to its inequities, inefficiency, and complexity. Here are several suggestions for adapting or curtailing the concession.

So, we are not spending our super balances. So what!

A Grattan Institute report suggests lifetime annuities as a solution to people not spending their super balances. The issue is whether underspending is the real problem or a sign of more fundamental failings in our retirement system.

What Warren Buffett isn’t saying speaks volumes

Warren Buffett's annual shareholder letter has been fixture for avid investors for decades. In his latest letter, Buffett is reticent on many key topics, but his actions rather than words are sending clear signals to investors.

Latest Updates

Shares

16 ASX stocks to buy and hold forever, updated

This time last year, I highlighted 16 ASX stocks that investors could own indefinitely. One year on, I look at whether there should be any changes to the list of stocks as well as which companies are worth buying now. 

Superannuation

2025-26 super thresholds – key changes and implications

The ABS recently released figures which are used to determine key superannuation rates and thresholds that will apply from 1 July 2025. This outlines the rates and thresholds that are changing and those that aren’t.  

Shares

The naysayers may be wrong again on the Big Four banks

While much of the investment industry recommends selling the banks, many were saying the same thing 12 months ago. The reporting season shows why bank shareholders should be rewarded for ignoring the current market noise.

Superannuation

Unpacking investment risk in superannuation

Understanding investment risk in superannuation is crucial for your retirement account. Here's a guide on how to define, take, and manage risk to select the right investment mix tailored to your unique circumstances.

Economy

This 'forgotten' inflation indicator signals better times ahead

Money supply provides an early and good read on whether the cash rate setting is transmitting to accelerating, steady or slowing price pressures. This explores recent data on money supply and what lies ahead for inflation.  

Investment strategies

The biggest and most ignored catalyst for emerging market stocks

Relative valuations and superior GDP growth alone are not compelling enough reasons for an improvement in emerging market equity returns. Earnings growth looks more likely to revive the asset class’s strong long-term record.

Property

Has Australian commercial property bottomed?

Commercial property took a beating in recent years as markets adjusted to higher interest rates. From here, strong demand tailwinds and a sharp fall in fresh supply could support solid returns for the best assets.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.